The Study of Efficacy and Induction –Abortion Interval of Single Dose of Vaginal Misoprostol 800 µg In First Trimester Abortion.

Abstract

Background: Medical abortion is a safe, effective means of terminating pregnancy provided the criteria are fulfilled. Hence acceptable in both the developing and developed countries of the world. The usage of pharmacological agents such as Mifepristone, Misoprostol or in combination in various regimens is adopted for MTP. Objectives: To know the efficacy and outcome of single dose of vaginal Misoprostol 800Ug in first trimester abortion. Material And Methods: This study was conducted over a period of 3 years at JLNMCH Bhagalpur. A total of 100 pregnant women up to 12 weeks of gestation wanting termination of pregnancy was recruited in this study. The efficacy, outcome, and induction abortion interval were studied in these cases. Results: In our case study 76% of the patients had complete abortion with single dose of 800ug Misoprostol and 4 % underwent check curettage due to profuse bleeding and retained products in uterus on USG. 16% of the cases needed second dose of 200ug of Misoprostol. The mean induction to abortion interval was 11.38hrs. 96% of the patients had complete abortion with medical method and only 4% underwent surgical curettage due to profuse bleeding after the single dose. The mean haemoglobin prior to induction was 9.76gm% and post expulsion was 9.59gm % respectively. No statistical difference was noted. The incidence of side effects like nausea, vomiting and diarrhoea was minimal and transitory. No major complications noted. Conclusion: Vaginal PGE1 analogue is very safe and effective method of termination of first trimester of pregnancy. Single high dose of vaginal Misoprostol 800ug is found to be cost -effective with minimal side effects, shorter Induction Abortion interval and a day care procedure with good success rate and can be adopted at community and primary health care units to reduce the maternal morbidity and mortality in developing countries like India due to unwanted pregnancies and unsafe abortions.

Authors and Affiliations

Dr. Punam Glory Moses

Keywords

Related Articles

The applications of gene therapy in Oral Cancer: A Review.

In gene therapy genes or short oligonucleotide sequences are used as therapeutic molecules.it has been used to treat defective genes. DNA encoding a with therapeutic vector main machinery of gene therapy.In...

Molecular diagnosis and Importance of Genetic Counseling in subjects and family members with a clinical suspicion of Fragile X Syndrome

Background: Fragile X Syndrome (FXS) is the most common single gene cause of learning disability, hyperactivity and mild to profound Mental retardation (MR) in male patient. Permutation status can lead to premature ovari...

Comparative Study - To Analyze Effect of Ultra Sound and Ultrasound, Along With Therapeutic Taping On Pain and Hand Grip Strength in Patients with Tennis Elbow.

Purpose: The objective of the present study is to compare the effect of ultrasound and ultrasound along with therapeutic taping on pain and hand grip strength in patients with tennis elbow. Metho...

Anaesthetic Management of Cervical Spine Surgery for Traumatic Tetraplegia in 32 Weeks Pregnant Patient: A Case Report and Literature Review.

A 30 year old woman with 32 weeks pregnancy and hypothyroidism admitted in the hospital with traumatic cervical SCI (Spinal Cord Injury) with quadriplegia but intact sensation (ASIA-B). Patient w...

The Study of Efficacy of Sublingual Misoprostol in Termination of Early Pregnancy

Introduction: Nearly 20% of all confirmed pregnancies end in spontaneous abortion. Misoprostol’s use in early pregnancy failure is varied and dose and route are not well established. Aim: To study the...

Download PDF file
  • EP ID EP491077
  • DOI -
  • Views 90
  • Downloads 0

How To Cite

Dr. Punam Glory Moses (2018). The Study of Efficacy and Induction –Abortion Interval of Single Dose of Vaginal Misoprostol 800 µg In First Trimester Abortion.. International Journal of Medical Science And Advanced Clinical Research (IJMACR), 1(6), 82-85. https://europub.co.uk/articles/-A-491077